Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Aptevo Therapeutics Inc. shareholders approved Election of Directors at the 2023-06-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
The following two nominees, each of whom were named in the Proxy Statement, were elected to serve on the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, based on the following votes: FOR WITHHELD BROKER NON-VOTES Zsolt Harsanyi, Ph.D. 967,133 343,098 2,566,806 Barbara Lopez Kunz 716,175 594,056 2,566,806
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Aptevo Therapeutics Inc. shareholders approved Approval, on a non-binding advisory basis, of the Company's named executive officer compensation as disclosed in the Proxy Statement at the 2023-06-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 969,344 332,792 8,095 2,566,806
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Aptevo Therapeutics Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm for 2023 at the 2023-06-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-02
Exact text from the filing
FOR AGAINST ABSTAIN 3,581,428 276,500 19,109
View on SEC.gov